Tech Company Financing Transactions
Epoch Biodesign Funding Round
Extantia Capital, Happiness Capital and Kompas invested in a $12 million venture round for Epoch Biodesign. The round was announced on 3/25/2026.
Transaction Overview
Company Name
Announced On
3/25/2026
Transaction Type
Venture Equity
Amount
$12,000,000
Round
Undisclosed
Proceeds Purpose
The funding will be used to expand Epoch's global commercialisation efforts and deepen partnerships across industries, including apparel and automotive.
Company Information
Company Status
Private & Independent
Industry
Environmental
Mailing Address
10 Finsbury Square
London England, EC2 1AJ
UK
London England, EC2 1AJ
UK
Phone
Undisclosed
Website
Email Address
Overview
Epoch is the Total BioDesign company developing natural solutions to unnatural problems. Combining the last thirty years of progress in computational and biological sciences with new ideas, deep industry knowledge, and academic expertise, we're on a mission to scale and industrialise biology to solve our biggest climate challenges.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jacob Nathan
Chief Technical Officer
Douglas Kell
Co-Founder
Beatrix Ellis
Browse more venture capital transactions:
Prev: 3/25/2026: Endogenex venture capital transaction
Next: 3/25/2026: Adonis venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to document every notable VC transaction. VC investment data records reported here are sourced from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs